Hepion Pharmaceuticals, Inc. (HEPA): Price and Financial Metrics

Hepion Pharmaceuticals, Inc. (HEPA): $0.69

0.00 (0.04%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

C

Add HEPA to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#262 of 358

in industry

HEPA Price/Volume Stats

Current price $0.69 52-week high $4.47
Prev. close $0.69 52-week low $0.55
Day low $0.66 Volume 40,300
Day high $0.74 Avg. volume 84,959
50-day MA $0.67 Dividend yield N/A
200-day MA $1.25 Market Cap 4.83M

HEPA Stock Price Chart Interactive Chart >


Hepion Pharmaceuticals, Inc. (HEPA) Company Bio


Hepion Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development of pleiotropic drug therapy for the treatment of chronic liver diseases in the United States. It is involved in developing CRV431, a cyclophilin inhibitor that has completed the Phase I clinical trials for multiple biochemical pathways involved in the progression of liver diseases; and Tenofovir exalidex, a lipid acyclic nucleoside phosphonate that delivers high intracellular concentrations of the active antiviral agent tenofovir diphosphate for the treatment of Hepatitis B. The company was formerly known as ContraVir Pharmaceuticals, Inc. and changed its name to Hepion Pharmaceuticals, Inc. in July 2019. Hepion Pharmaceuticals, Inc. was incorporated in 2013 and is headquartered in Edison, New Jersey.


HEPA Latest News Stream


Event/Time News Detail
Loading, please wait...

HEPA Latest Social Stream


Loading social stream, please wait...

View Full HEPA Social Stream

HEPA Price Returns

1-mo -0.26%
3-mo -9.21%
6-mo -38.39%
1-year -76.92%
3-year -97.20%
5-year -99.04%
YTD -78.70%
2023 -46.05%
2022 -73.66%
2021 -47.95%
2020 -59.14%
2019 -72.65%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!